In this study, a multiple linear regression model to evaluate the risk of morbidity and mortality of ischemic cardiovascular disease is demonstrated. In this model, predictor variables are selected from physiological chemicals in a blood test of the subjects. Meanwhile, the calculated risk score is selected as a response variable. Four major latent variables including hepatic, nephric, metabolic, and BMI (Body Mass Index) are revealed by performing statistical and principal component analysis for the collected survey data. The analyzed result also shows that the cardiac disorder is correlated with symptoms of abnormal BMI, hepatic disorder, nephric disorder, and metabolic disorder. Thus, the risk of morbidity and mortality of ischemic cardi...
Many predictive models exist that predict risk of common cardiometabolic conditions. However, a vast...
Many predictive models exist that predict risk of common cardiometabolic conditions. However, a vast...
To develop a method for assessing preclinical cardiovascular disease risk, models of resting cardiov...
In this study, a multiple linear regression model to evaluate the risk of morbidity and mortality of...
Abstract: In this study, a multiple linear regression model to evaluate the risk of morbidity and mo...
The paper focuses on tasks of creating and implementing a new technique aimed at assessing ischemic ...
At the worldwide level, heart disease is the leading cause of death. The primary goals of this study...
At the worldwide level, heart disease is the leading cause of death. The primary goals of this study...
An individual's overall cardiovascular risk should guide appropriate therapy and patient management....
An individual's overall cardiovascular risk should guide appropriate therapy and patient management....
Metabolic syndrome (MetS) is proposed as a predictor for cardiovascular disease (CVD). It involves t...
In 2010, World Health Organization (WHO) predicted cardiovascular cases cause 73% death rate from to...
AbstractLogistic regression has now become an essential part of medical data analysis that uses a bi...
Background: Cardiovascular risk assessment in the clinical practice is mostly based on risk charts, ...
Aims The aims of the study are to follow the correlation of СAD development with various clinical...
Many predictive models exist that predict risk of common cardiometabolic conditions. However, a vast...
Many predictive models exist that predict risk of common cardiometabolic conditions. However, a vast...
To develop a method for assessing preclinical cardiovascular disease risk, models of resting cardiov...
In this study, a multiple linear regression model to evaluate the risk of morbidity and mortality of...
Abstract: In this study, a multiple linear regression model to evaluate the risk of morbidity and mo...
The paper focuses on tasks of creating and implementing a new technique aimed at assessing ischemic ...
At the worldwide level, heart disease is the leading cause of death. The primary goals of this study...
At the worldwide level, heart disease is the leading cause of death. The primary goals of this study...
An individual's overall cardiovascular risk should guide appropriate therapy and patient management....
An individual's overall cardiovascular risk should guide appropriate therapy and patient management....
Metabolic syndrome (MetS) is proposed as a predictor for cardiovascular disease (CVD). It involves t...
In 2010, World Health Organization (WHO) predicted cardiovascular cases cause 73% death rate from to...
AbstractLogistic regression has now become an essential part of medical data analysis that uses a bi...
Background: Cardiovascular risk assessment in the clinical practice is mostly based on risk charts, ...
Aims The aims of the study are to follow the correlation of СAD development with various clinical...
Many predictive models exist that predict risk of common cardiometabolic conditions. However, a vast...
Many predictive models exist that predict risk of common cardiometabolic conditions. However, a vast...
To develop a method for assessing preclinical cardiovascular disease risk, models of resting cardiov...